Unknown

Dataset Information

0

Resveratrol Maintains Lipid Metabolism Homeostasis via One of the Mechanisms Associated with the Key Circadian Regulator Bmal1.


ABSTRACT: Resveratrol (RES) possesses anti-inflammatory and anti-oxidant activities, and it can prevent liver lipid metabolism disorders in obese and diabetic individuals. This study elucidated the mechanisms of brain and muscle Arnt-like protein-1 (Bmal1) in the protective effects of RES against liver lipid metabolism disorders. The results indicated that RES ameliorated free fatty acid (FFA)-induced (oleic acid (OA): palmitic acid (PA) = 2:1) glycolipid metabolic disorders in hepatocytes. Simultaneously, RES partially reverted the relatively shallow daily oscillations of FFA-induced circadian clock gene transcription and protein expression in HepG2 cells. RES also attenuated FFA-triggered reactive oxygen species (ROS) secretion and restored mitochondrial membrane potential consumption, as well as the restoration of mitochondrial respiratory complex expression. This study provides compelling evidence that RES controls intracellular lipid metabolic imbalance in a Bmal1-dependent manner. Overall, RES may serve as a promising natural nutraceutical for the regulation of lipid metabolic disorders relevant to the circadian clock.

SUBMITTER: Li J 

PROVIDER: S-EPMC6718980 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Resveratrol Maintains Lipid Metabolism Homeostasis via One of the Mechanisms Associated with the Key Circadian Regulator Bmal1.

Li Jing J   Wei Liping L   Zhao Caicai C   Li Junyi J   Liu Zhigang Z   Zhang Min M   Wang Yutang Y  

Molecules (Basel, Switzerland) 20190812 16


Resveratrol (RES) possesses anti-inflammatory and anti-oxidant activities, and it can prevent liver lipid metabolism disorders in obese and diabetic individuals. This study elucidated the mechanisms of brain and muscle Arnt-like protein-1 (Bmal1) in the protective effects of RES against liver lipid metabolism disorders. The results indicated that RES ameliorated free fatty acid (FFA)-induced (oleic acid (OA): palmitic acid (PA) = 2:1) glycolipid metabolic disorders in hepatocytes. Simultaneously  ...[more]

Similar Datasets

| S-EPMC10454516 | biostudies-literature
| S-EPMC7613259 | biostudies-literature
| S-EPMC8914330 | biostudies-literature
| S-EPMC8746294 | biostudies-literature
| S-EPMC10449865 | biostudies-literature
| S-EPMC5492176 | biostudies-literature
| S-EPMC6422340 | biostudies-literature
| S-EPMC4864379 | biostudies-literature
| S-EPMC6322248 | biostudies-literature
| S-EPMC5830501 | biostudies-literature